Business Context and Reporting Period
Company: Zimmer Holdings, Inc. (Note: Filing lists "Zimmer Holdings, Inc."; request metadata references "Zimmer Biomet Holdings, Inc.")
Filing Type: Form 8-K (Current Report)
Date: January 28, 2010
Reporting Period: Quarter and full year ended December 31, 2009.
This filing serves to report the results of operations for the specified period. The detailed financial data is contained in an attached press release (Exhibit 99.1) and is incorporated by reference. The filing text itself does not contain specific numerical values for revenue, profit, or cash flow.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the attached Exhibit 99.1 (Press Release).
The filing highlights the use of two types of non-GAAP financial measures to evaluate performance:
- Constant Currency Sales: Sales translated at predetermined exchange rates to exclude foreign currency fluctuations.
- Adjusted Operating Performance: Adjusted net earnings and diluted EPS excluding specific one-time or non-recurring items.
Material Changes and Unusual Items
Management utilizes adjusted metrics to exclude the following items to provide a clearer view of ongoing operations:
- 2009 Adjustments:
- Inventory step-up and acquisition, integration, realignment, and related expenses (net of tax).
- Goodwill impairment charge related to the U.S. Spine business.
- Net curtailment and settlement gain.
- Provision for known and anticipated claims regarding the voluntary suspension of the Durom Acetabular Component ("Durom Cup") in the U.S. (net of tax).
- 2008 Adjustments (for comparison):
- Inventory step-up and acquisition/integration expenses.
- Provision for Durom Cup claims.
- Tax benefit related to a 2007 civil settlement paid to the U.S. government.
Guidance, Outlook, and Risks
Guidance: The filing notes that the attached press release includes projected adjusted diluted EPS for the full year 2010. Specific guidance figures are not present in the 8-K text.
Risks and Contingencies:
- Product Suspension: Ongoing financial impact from the voluntary suspension of marketing and distribution of the Durom Cup in the U.S.
- Goodwill Impairment: A charge was recorded related to the U.S. Spine business segment.
- Legal/Regulatory: Historical exposure to civil settlements with the U.S. government.
Management Commentary: Management asserts that non-GAAP measures offer meaningful period-to-period comparisons and better identify operating trends by masking distortions from the items listed above. All non-GAAP measures are reconciled to GAAP in the press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific GAAP and non-GAAP revenue, net earnings, and EPS figures for Q4 and full-year 2009.
- Verify the specific dollar amount of the goodwill impairment charge for the U.S. Spine business.
- Confirm the magnitude of the provision for claims related to the Durom Cup suspension.
- Examine the reconciliation table in the press release to understand the exact tax impact of excluded items.
- Check the specific projected adjusted diluted EPS for 2010 mentioned in the press release.